Reprint
Cardiomyopathies: Current Treatment and Future Options
Edited by
March 2024
218 pages
- ISBN978-3-7258-0373-6 (Hardback)
- ISBN978-3-7258-0374-3 (PDF)
This book is a reprint of the Special Issue Cardiomyopathies: Current Treatment and Future Options that was published in
Medicine & Pharmacology
Public Health & Healthcare
Summary
The reprint highlights different forms of cardiomyopathy, such as RBM20, filamin C, and lamin A/C cardiomyopathy. Diagnostic and new treatment options are presented in arrhythmogenic, hypertrophic, dilated, and restrictive cardiomyopathy. As a special form of cardiomyopathy, the value of ajmaline testing in Brugada syndrome is highlighted. This reprint provides new information on the common forms of cardiomyopathy and highlights new approaches.
Format
- Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
cardiomyopathy; hypertrophic; dilated; arrhythmogenic; filamin C; cardiomyopathy; gene mutations; Emery–Dreifuss muscular dystrophy; LMNA; EMD; emerin; lamin A/C; ajmaline challenge; Brugada syndrome; early repolarization syndrome; arrhythmogenic right ventricular cardiomyopathy; long QT syndrome; hypertrophic cardiomyopathy; parvovirus B19; dilated inflammatory cardiomyopathy; telbivudine; noncompaction cardiomyopathy; NCCM-diagnostic-therapy-prognosis; cardiomyopathy classification; LVNC; LVHT; phenotype; congenital heart disease; arrhythmogenic cardiomyopathy; risk stratification; drug therapy; implantable cardioverter defibrillator; catheter ablation; treatment; Fabry; cardiomyopathy; treatment; options; takotsubo syndrome; takotsubo cardiomyopathy; therapy of takotsubo syndrome; therapy of takotsubo cardiomyopathy; dilated cardiomyopathy; RBM20; arrhythmia; heart failure; gene therapy; alternative splicing; restrictive cardiomyopathy; cardiomyopathy; cardiovascular genetics; desmin; troponin; filamin-C; transthyretin amyloid cardiomyopathy; TTR amyloid; cardiac amyloidosis; tafamidis; clinical development; arrhythmogenic left ventricular cardiomyopathy; pregnancy; desmoplakin; filamin C; plakofillin-2; takotsubo; cardiomyopathy; trigger; stress; outcome; cardiomyopathies; hypertrophic cardiomyopathy; alcohol septal ablation; hypertrophic obstructive cardiomyopathy; septal reduction treatment